Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Radius Health, Inc. (NONE) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Radius Health, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1428522.
Total stock buying since 2014: $183,489,869.
Total stock sales since 2014: $12,278,002.
Total stock option exercises since 2014: $1,497,194.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2022 | 2,710,790 | $23,077,717 | 0 | $0 | 0 | $0 |
| 2021 | 2,452,429 | $19,380,833 | 1,692 | $32,750 | 0 | $0 |
| 2020 | 574,029 | $7,137,722 | 9,927 | $178,128 | 0 | $0 |
| 2019 | 117,300 | $2,643,890 | 15,264 | $343,079 | 33,600 | $0 |
| 2018 | 857,363 | $21,930,651 | 0 | $0 | 0 | $0 |
| 2017 | 1,356,078 | $46,856,746 | 0 | $0 | 63,032 | $156,549 |
| 2016 | 88,359 | $3,210,206 | 0 | $0 | 10,000 | $78,000 |
| 2015 | 666,300 | $37,852,104 | 181,819 | $11,724,045 | 186,819 | $1,262,645 |
| 2014 | 2,675,000 | $21,400,000 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2022-08 | 1,682,966 | $16,947,466 | 0 | $0 | 0 | $0 |
| 2022-05 | 477,824 | $2,661,001 | 0 | $0 | 0 | $0 |
| 2022-01 | 550,000 | $3,469,250 | 0 | $0 | 0 | $0 |
| 2021-12 | 2,202,429 | $16,245,083 | 0 | $0 | 0 | $0 |
| 2021-09 | 250,000 | $3,135,750 | 0 | $0 | 0 | $0 |
| 2021-03 | 0 | $0 | 370 | $7,725 | 0 | $0 |
| 2021-02 | 0 | $0 | 1,322 | $25,025 | 0 | $0 |
| 2020-11 | 100,000 | $1,426,200 | 0 | $0 | 0 | $0 |
| 2020-09 | 399,029 | $4,593,797 | 0 | $0 | 0 | $0 |
| 2020-07 | 25,000 | $330,175 | 0 | $0 | 0 | $0 |
| 2020-04 | 50,000 | $787,550 | 0 | $0 | 0 | $0 |
| 2020-02 | 0 | $0 | 9,927 | $178,128 | 0 | $0 |
| 2019-11 | 100,000 | $2,300,300 | 0 | $0 | 0 | $0 |
| 2019-07 | 0 | $0 | 1,584 | $38,966 | 0 | $0 |
| 2019-06 | 2,500 | $54,535 | 0 | $0 | 0 | $0 |
| 2019-05 | 2,000 | $42,860 | 0 | $0 | 0 | $0 |
| 2019-04 | 0 | $0 | 13,680 | $304,113 | 0 | $0 |
| 2019-03 | 12,800 | $246,195 | 0 | $0 | 0 | $0 |
| 2019-02 | 0 | $0 | 0 | $0 | 33,600 | $0 |
| 2018-12 | 123,000 | $1,854,210 | 0 | $0 | 0 | $0 |
| 2018-08 | 289,363 | $6,071,081 | 0 | $0 | 0 | $0 |
| 2018-07 | 50,000 | $1,363,800 | 0 | $0 | 0 | $0 |
| 2018-06 | 50,000 | $1,367,850 | 0 | $0 | 0 | $0 |
| 2018-05 | 100,000 | $2,912,700 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-08-11 | Rosen David Efraim | Buy | 1,678,954 | 10.07 | 16,907,066 |
| 2022-08-10 | Rosen David Efraim | Buy | 4,012 | 10.07 | 40,400 |
| 2022-05-18 | Bb Biotech Ag (10% Owner) | Buy | 477,824 | 5.57 | 2,661,001 |
| 2022-01-06 | Bb Biotech Ag (10% Owner) | Buy | 300,000 | 6.32 | 1,894,500 |
| 2022-01-05 | Bb Biotech Ag (10% Owner) | Buy | 250,000 | 6.30 | 1,574,750 |
| 2021-12-16 | Rosen David Efraim | Buy | 146,685 | 7.08 | 1,037,796 |
| 2021-12-15 | Rosen David Efraim | Buy | 180,744 | 6.77 | 1,223,636 |
| 2021-12-14 | Rosen David Efraim | Buy | 94,103 | 6.81 | 640,935 |
| 2021-12-13 | Rosen David Efraim | Buy | 187,391 | 7.08 | 1,326,728 |
| 2021-12-10 | Rosen David Efraim | Buy | 768,171 | 7.17 | 5,511,626 |
| 2021-12-09 | Rosen David Efraim | Buy | 264,644 | 7.58 | 2,007,060 |
| 2021-12-08 | Rosen David Efraim | Buy | 560,691 | 8.02 | 4,497,302 |
| 2021-09-29 | Bb Biotech Ag (10% Owner) | Buy | 100,000 | 12.95 | 1,294,500 |
| 2021-09-22 | Bb Biotech Ag (10% Owner) | Buy | 150,000 | 12.28 | 1,841,250 |
| 2021-03-05 | Chopas James George (Principal Finance Accounting) | Sale | 370 | 20.88 | 7,725 |
| 2021-02-25 | Grausso Sal (Chief Commercial Officer) | Sale | 1,322 | 18.93 | 25,025 |
| 2020-11-05 | Bb Biotech Ag (10% Owner) | Buy | 100,000 | 14.26 | 1,426,200 |
| 2020-09-14 | Bb Biotech Ag (10% Owner) | Buy | 200,000 | 11.69 | 2,338,600 |
| 2020-09-11 | Bb Biotech Ag (10% Owner) | Buy | 199,029 | 11.33 | 2,255,197 |
| 2020-07-08 | Bb Biotech Ag (10% Owner) | Buy | 25,000 | 13.21 | 330,175 |
| 2020-04-30 | Bb Biotech Ag (10% Owner) | Buy | 50,000 | 15.75 | 787,550 |
| 2020-02-26 | Kelly Joseph Francis (Sr. VP of Sales and Marketing) | Sale | 889 | 17.93 | 15,942 |
| 2020-02-26 | Carmona Jose (Chief Financial Officer) | Sale | 1,292 | 17.93 | 23,169 |
| 2020-02-26 | Hughes Owen (Director) | Sale | 2,750 | 17.95 | 49,362 |
| 2020-02-26 | Morris Charles Q (Chief Medical Officer) | Sale | 1,256 | 17.93 | 22,523 |
| 2020-02-26 | Rosenberg Anthony (Director) | Sale | 1,815 | 17.95 | 32,579 |
| 2020-02-26 | Dere Willard H (Director) | Sale | 1,925 | 17.95 | 34,553 |
| 2019-11-06 | Bb Biotech Ag (10% Owner) | Buy | 100,000 | 23.00 | 2,300,300 |
| 2019-07-01 | Rosenberg Anthony (Director) | Sale | 1,584 | 24.60 | 38,966 |
| 2019-06-07 | Kelly Joseph Francis (Sr. VP of Sales and Marketing) | Buy | 2,500 | 21.81 | 54,535 |
| 2019-05-10 | Kelly Joseph Francis (Sr. VP of Sales and Marketing) | Buy | 2,000 | 21.43 | 42,860 |
| 2019-04-16 | Hughes Owen (Director) | Sale | 2,400 | 22.22 | 53,328 |
| 2019-04-16 | Graves Kurt (Director) | Sale | 4,800 | 22.32 | 107,136 |
| 2019-04-16 | Dere Willard H (Director) | Sale | 1,680 | 22.22 | 37,329 |
| 2019-04-11 | Roychowdhury Debasish (Director) | Sale | 4,800 | 22.15 | 106,320 |
| 2019-03-05 | Hopfield Jessica (Director) | Buy | 12,800 | 19.23 | 246,195 |
| 2019-02-13 | Roychowdhury Debasish (Director) | Option Ex | 4,800 | .00 | 0 |
| 2019-02-13 | Hughes Owen (Director) | Option Ex | 4,800 | .00 | 0 |
| 2019-02-13 | Rosenberg Anthony (Director) | Option Ex | 4,800 | .00 | 0 |
| 2019-02-13 | Friedman Cathy (Director) | Option Ex | 4,800 | .00 | 0 |
| 2019-02-13 | Graves Kurt (Director) | Option Ex | 4,800 | .00 | 0 |
| 2019-02-13 | Dere Willard H (Director) | Option Ex | 4,800 | .00 | 0 |
| 2019-02-13 | Garnier Jean Pierre (Director) | Option Ex | 4,800 | .00 | 0 |
| 2018-12-20 | Bb Biotech Ag (10% Owner) | Buy | 60,000 | 14.48 | 868,800 |
| 2018-12-17 | Kelly Joseph Francis (Sr. VP of Sales and Marketing) | Buy | 3,000 | 15.71 | 47,130 |
| 2018-12-14 | Bb Biotech Ag (10% Owner) | Buy | 60,000 | 15.64 | 938,280 |
| 2018-08-20 | Bb Biotech Ag (10% Owner) | Buy | 60,000 | 19.65 | 1,178,820 |
| 2018-08-15 | Bb Biotech Ag (10% Owner) | Buy | 69,363 | 20.78 | 1,441,501 |
| 2018-08-14 | Bb Biotech Ag (10% Owner) | Buy | 100,000 | 20.87 | 2,086,900 |
| 2018-08-08 | Bb Biotech Ag (10% Owner) | Buy | 60,000 | 22.73 | 1,363,860 |
| 2018-07-25 | Bb Biotech Ag (10% Owner) | Buy | 50,000 | 27.28 | 1,363,800 |
| 2018-06-11 | Bb Biotech Ag (10% Owner) | Buy | 50,000 | 27.36 | 1,367,850 |
| 2018-05-23 | Bb Biotech Ag (10% Owner) | Buy | 40,000 | 28.91 | 1,156,320 |
| 2018-05-21 | Bb Biotech Ag (10% Owner) | Buy | 60,000 | 29.27 | 1,756,380 |
| 2018-04-19 | Bb Biotech Ag (10% Owner) | Buy | 40,000 | 33.80 | 1,351,920 |
| 2018-04-05 | Bb Biotech Ag (10% Owner) | Buy | 50,000 | 36.58 | 1,828,850 |
| 2018-03-02 | Bb Biotech Ag (10% Owner) | Buy | 80,000 | 32.52 | 2,601,440 |
| 2018-02-09 | Bb Biotech Ag (10% Owner) | Buy | 75,000 | 34.38 | 2,578,800 |
| 2017-11-14 | Bb Biotech Ag (10% Owner) | Buy | 50,000 | 26.25 | 1,312,400 |
| 2017-11-10 | Hatzis-schoch Brent (Sr. VP, General Counsel) | Buy | 1,778 | 28.09 | 49,942 |
| 2017-11-07 | Hoiland Jesper (President and CEO) | Buy | 6,800 | 29.04 | 197,451 |
| 2017-11-03 | Bb Biotech Ag (10% Owner) | Buy | 50,000 | 29.15 | 1,457,600 |
| 2017-10-26 | Bb Biotech Ag (10% Owner) | Buy | 50,000 | 30.95 | 1,547,550 |
| 2017-10-25 | Bb Biotech Ag (10% Owner) | Buy | 50,000 | 32.85 | 1,642,400 |
| 2017-09-15 | Hoiland Jesper (President and CEO) | Buy | 6,100 | 32.72 | 199,610 |
| 2017-09-14 | Carmona Jose (Chief Financial Officer) | Buy | 3,000 | 32.83 | 98,502 |
| 2017-09-14 | Bb Biotech Ag (10% Owner) | Buy | 50,000 | 32.95 | 1,647,250 |
| 2017-09-13 | Bb Biotech Ag (10% Owner) | Buy | 100,000 | 33.71 | 3,370,800 |
| 2017-09-12 | Bb Biotech Ag (10% Owner) | Buy | 50,000 | 35.42 | 1,770,799 |
| 2017-09-05 | Bb Biotech Ag (10% Owner) | Buy | 50,000 | 36.75 | 1,837,650 |
| 2017-08-16 | Bb Biotech Ag (10% Owner) | Buy | 60,000 | 35.98 | 2,158,560 |
| 2017-08-10 | Bb Biotech Ag (10% Owner) | Buy | 75,000 | 34.26 | 2,569,500 |
| 2017-08-09 | Bb Biotech Ag (10% Owner) | Buy | 75,000 | 35.67 | 2,675,550 |
| 2017-05-30 | Bb Biotech Ag (10% Owner) | Buy | 40,000 | 34.21 | 1,368,360 |
| 2017-05-25 | Bb Biotech Ag (10% Owner) | Buy | 40,000 | 36.25 | 1,450,040 |
| 2017-05-18 | Bb Biotech Ag (10% Owner) | Buy | 50,000 | 34.41 | 1,720,349 |
| 2017-05-17 | Bb Biotech Ag (10% Owner) | Buy | 18,000 | 32.98 | 593,658 |
| 2017-05-16 | Bb Biotech Ag (10% Owner) | Buy | 17,000 | 33.92 | 576,725 |
| 2017-05-12 | Bb Biotech Ag (10% Owner) | Buy | 15,000 | 34.00 | 510,000 |
| 2017-05-09 | Bb Biotech Ag (10% Owner) | Buy | 50,000 | 35.93 | 1,796,500 |
| 2017-05-08 | Bb Biotech Ag (10% Owner) | Buy | 22,800 | 35.60 | 811,634 |
| 2017-05-05 | Bb Biotech Ag (10% Owner) | Buy | 20,600 | 35.55 | 732,288 |
| 2017-05-02 | Bb Biotech Ag (10% Owner) | Buy | 75,000 | 33.91 | 2,542,950 |
| 2017-05-01 | Bb Biotech Ag (10% Owner) | Buy | 150,000 | 35.39 | 5,308,650 |
| 2017-04-25 | Harvey Brian Nicholas (Sr. VP and CFO) | Option Ex | 39,616 | 2.74 | 108,547 |
| 2017-03-21 | Bb Biotech Ag (10% Owner) | Buy | 50,000 | 35.83 | 1,791,650 |
| 2017-03-20 | Harvey Brian Nicholas (Sr. VP and CFO) | Option Ex | 23,416 | 2.05 | 48,002 |
| 2017-03-17 | Bb Biotech Ag (10% Owner) | Buy | 30,000 | 38.41 | 1,152,240 |
| 2017-03-15 | Bb Biotech Ag (10% Owner) | Buy | 44,469 | 39.96 | 1,776,803 |
| 2017-03-14 | Bb Biotech Ag (10% Owner) | Buy | 17,252 | 40.00 | 690,062 |
| 2017-03-10 | Bb Biotech Ag (10% Owner) | Buy | 38,279 | 39.17 | 1,499,273 |
| 2016-10-25 | Ward Robert (President & CEO) | Option Ex | 10,000 | 7.80 | 78,000 |
| 2016-01-25 | Fitzpatrick Lorraine A. (Chief Medical Officer) | Buy | 100 | 37.97 | 3,797 |
| 2016-01-22 | Bb Biotech Ag (10% Owner) | Buy | 38,259 | 31.67 | 1,211,509 |
| 2016-01-13 | Bb Biotech Ag (10% Owner) | Buy | 50,000 | 39.90 | 1,994,900 |
| 2015-11-25 | Fitzpatrick Lorraine A. (Chief Medical Officer) | Buy | 100 | 60.59 | 6,059 |
| 2015-11-23 | Ward Robert (President & CEO) | Sale | 25,000 | 62.77 | 1,569,125 |
| 2015-11-23 | Ward Robert (President & CEO) | Option Ex | 25,000 | 7.80 | 195,000 |
| 2015-11-12 | Hattersley Gary (Chief Scientific Officer) | Sale | 5,683 | 75.00 | 426,225 |
| 2015-11-12 | Hattersley Gary (Chief Scientific Officer) | Option Ex | 5,683 | 2.74 | 15,571 |
| 2015-11-03 | Hattersley Gary (Chief Scientific Officer) | Sale | 13,333 | 70.00 | 933,310 |
| 2015-11-03 | Hattersley Gary (Chief Scientific Officer) | Option Ex | 13,333 | 2.74 | 36,532 |
| 2015-10-23 | Hattersley Gary (Chief Scientific Officer) | Sale | 11,302 | 65.00 | 734,630 |
| 2015-10-23 | Hattersley Gary (Chief Scientific Officer) | Option Ex | 11,302 | 2.73 | 30,910 |
| 2015-10-21 | Hattersley Gary (Chief Scientific Officer) | Sale | 1,501 | 65.36 | 98,105 |
| 2015-10-21 | Hattersley Gary (Chief Scientific Officer) | Option Ex | 1,501 | 3.42 | 5,133 |
| 2015-10-21 | Ward Rob (President & CEO) | Sale | 50,000 | 61.99 | 3,099,500 |
| 2015-10-21 | Ward Rob (President & CEO) | Option Ex | 50,000 | 7.80 | 390,000 |
| 2015-09-14 | Snow David P. (Chief Commercial Officer) | Buy | 6,000 | 69.79 | 418,740 |
| 2015-08-31 | Purandare Dinesh (SVP Global Oncology/Commercial) | Buy | 200 | 62.20 | 12,440 |
| 2015-08-21 | Bb Biotech Ag (10% Owner) | Buy | 50,000 | 63.45 | 3,172,250 |
| 2015-08-20 | Bb Biotech Ag (10% Owner) | Buy | 50,000 | 64.56 | 3,227,750 |
| 2015-08-17 | Graves Kurt (Director) | Sale | 22,694 | 70.00 | 1,588,580 |
| 2015-08-17 | Graves Kurt (Director) | Option Ex | 22,694 | 7.34 | 166,573 |
| 2015-08-10 | Graves Kurt (Director) | Sale | 2,306 | 70.00 | 161,420 |
| 2015-08-10 | Graves Kurt (Director) | Option Ex | 2,306 | 7.34 | 16,926 |
| 2015-07-23 | Bb Biotech Ag (10% Owner) | Buy | 250,000 | 74.00 | 18,500,000 |
| 2015-07-06 | Graves Kurt (Director) | Sale | 25,000 | 69.48 | 1,736,900 |
| 2015-07-06 | Graves Kurt (Director) | Option Ex | 25,000 | 7.34 | 183,500 |
| 2015-06-18 | Graves Kurt (Director) | Sale | 25,000 | 55.05 | 1,376,250 |
| 2015-06-18 | Graves Kurt (Director) | Option Ex | 25,000 | 7.34 | 183,500 |
| 2015-06-04 | Ward Robert (President and CEO) | Option Ex | 5,000 | 7.80 | 39,000 |
| 2015-05-01 | Bb Biotech Ag (10% Owner) | Buy | 50,000 | 36.46 | 1,822,950 |
| 2015-04-29 | Bb Biotech Ag (10% Owner) | Buy | 50,000 | 36.23 | 1,811,600 |
| 2015-04-28 | Bb Biotech Ag (10% Owner) | Buy | 50,000 | 36.59 | 1,829,300 |
| 2015-04-27 | Bb Biotech Ag (10% Owner) | Buy | 50,000 | 38.38 | 1,919,000 |
| 2015-03-06 | Bb Biotech Ag (10% Owner) | Buy | 75,000 | 47.08 | 3,531,150 |
| 2015-02-25 | Bb Biotech Ag (10% Owner) | Buy | 35,000 | 45.74 | 1,600,865 |
| 2014-06-11 | F2 Bioscience Vi L.p. | Buy | 587,500 | 8.00 | 4,700,000 |
| 2014-06-11 | Jovan-embiricos Morana (Director) | Buy | 587,500 | 8.00 | 4,700,000 |
| 2014-06-06 | Bb Biotech Ag (10% Owner) | Buy | 1,000,000 | 8.00 | 8,000,000 |
| 2014-06-05 | Brookside Capital Partners Fund Lp (10% Owner) | Buy | 500,000 | 8.00 | 4,000,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of NONE listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Radius Health, Inc. (symbol NONE, CIK number 1428522) see the Securities and Exchange Commission (SEC) website.